Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patients. [electronic resource]
- AIDS research and human retroviruses Nov 2007
- 1354-9 p. digital
Publication Type: Journal Article
0889-2229
10.1089/aid.2007.0091 doi
Adult Alanine Transaminase--blood Antiviral Agents--therapeutic use Aspartate Aminotransferases--blood CD4 Lymphocyte Count Drug Resistance, Viral--immunology Female HIV Infections--complications Hepacivirus--drug effects Hepatitis C--drug therapy Humans Interferons--therapeutic use Male Middle Aged Molecular Sequence Data Ribavirin--therapeutic use Viral Load